CYC682-12 (A4) Phase 3 Study of Oral Sapacitabine in Elderly Patients

• Research type

  Research Study

• Full title

  A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

• IRAS ID

  145125

• Contact name

  Jonathan Kell

• Contact email

  jonathan.kell@wales.nhs.uk

• Sponsor organisation

  Cyclacel Limited

• Eudract number

  2013-003586-34

• Clinicaltrials.gov Identifier

  NCT01303796

• REC name

  Wales REC 3

• REC reference

  14/WA/0012

• Date of REC Opinion

  6 May 2014

• REC opinion

  Further Information Favourable Opinion